Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.84 - $9.73 $103,284 - $146,923
15,100 Added 11.39%
147,700 $1.23 Million
Q2 2024

Aug 15, 2024

SELL
$6.87 - $11.34 $661,581 - $1.09 Million
-96,300 Reduced 42.07%
132,600 $949,000
Q1 2024

May 07, 2024

BUY
$5.11 - $8.76 $1.11 Million - $1.91 Million
217,700 Added 1943.75%
228,900 $1.98 Million
Q4 2023

Feb 14, 2024

SELL
$4.7 - $9.87 $441,330 - $926,792
-93,900 Reduced 89.34%
11,200 $73,000
Q3 2023

Nov 14, 2023

BUY
$9.14 - $12.85 $573,078 - $805,695
62,700 Added 147.88%
105,100 $1.05 Million
Q2 2023

Aug 11, 2023

BUY
$12.09 - $15.0 $302,250 - $375,000
25,000 Added 143.68%
42,400 $527,000
Q1 2023

May 16, 2023

BUY
$12.99 - $16.48 $226,026 - $286,752
17,400 New
17,400 $243,000
Q3 2022

Nov 14, 2022

SELL
$20.6 - $30.37 $422,300 - $622,585
-20,500 Reduced 47.02%
23,100 $590,000
Q2 2022

Aug 15, 2022

SELL
$26.05 - $37.48 $1.35 Million - $1.94 Million
-51,700 Reduced 54.25%
43,600 $1.24 Million
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $1.1 Million - $1.84 Million
-44,900 Reduced 32.03%
95,300 $3.36 Million
Q4 2021

Feb 14, 2022

BUY
$35.0 - $45.94 $738,500 - $969,334
21,100 Added 17.72%
140,200 $5.87 Million
Q3 2021

Nov 15, 2021

BUY
$36.8 - $60.62 $2.68 Million - $4.41 Million
72,700 Added 156.68%
119,100 $5.85 Million
Q2 2021

Aug 11, 2021

BUY
$32.46 - $45.0 $873,174 - $1.21 Million
26,900 Added 137.95%
46,400 $1.94 Million
Q1 2021

May 17, 2021

SELL
$25.8 - $38.49 $2.89 Million - $4.31 Million
-112,000 Reduced 85.17%
19,500 $695,000
Q4 2020

Feb 16, 2021

BUY
$24.5 - $30.86 $3.22 Million - $4.06 Million
131,500 New
131,500 $3.69 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $701M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.